Skip to content
Thursday, June 4
  • Finance
  • Health
  • Sports
  • World
  • Press Release
The Prime India

The Prime India

The Prime India

The Prime India

  • Business
  • Entertainment
  • Lifestyle
  • National
  • Technology
  • Education
  • Business
  • Entertainment
  • Lifestyle
  • National
  • Technology
  • Education
Trending Now
  • VAHH Chemicals Limited’s Initial Public Offering Opens on June 4 to June 8, 2026 with Price Fixed at Rs.60 Per Share
  • eYantra Ventures Limited Reports FY26 Annual Results
  • VMS TMT Limited Announces Q4 FY26 and FY26 Results
  • PPMS Group Joins with Prashant Janadri for Activatr – Distribution Platform for Consumer Brands
  • UMC Hospitals, Navi Mumbai Successfully Performs Its First Robotic Surgery
  • Srigee DLM Ltd Announces H2 FY26 and FY26 Results
Home>>Health>>Early Surgical Intervention in Parkinson’s Disease: Why Waiting Too Long May Limit Treatment Benefits? – Dr. Naren Nayak
Health

Early Surgical Intervention in Parkinson’s Disease: Why Waiting Too Long May Limit Treatment Benefits? – Dr. Naren Nayak

Ansh Singh
February 24, 2026

Thane (Maharashtra) [India], February 24: Patients with Parkinson’s disease require primary medication for their condition until they reach the point where doctors need to conduct surgery. Medical research currently demonstrates that patients with Parkinson’s disease can achieve better long-term results through surgical treatment when they undergo surgery at an early stage of their condition.

Dr. Naren Nayak, Consultant Neurosurgeon in Thane and Movement Disorder Specialist, states that patients who postpone their medical evaluation until their symptoms become severe will experience lower treatment success with advanced medical solutions which will hinder their progress toward better health. Parkinson’s disease causes patients to develop their condition in stages which results in medications producing “on-off” effects and multiple “on” and “off” symptom periods. People hold a false belief which Dr. Nayak describes as surgical treatment needing to wait until all other methods have shown no success. The early assessment process enables specialists to identify patients who will receive the most benefit from surgical procedures such as Deep Brain Stimulation (DBS) for Parkinson’s disease before their condition reaches a point which will result in less effective outcomes. Parkinson’s disease DBS treatment operates as an established surgical procedure which scientists have researched through medical studies. The treatment enables patients to control their tremors and rigidity along with their movement speed and motor fluctuations by using electrical stimulation to activate brain areas.

DBS proves effective when provided at correct times because it decreases medication requirements while sustaining daily symptom control and enabling substantial progress in patient independence. Early surgical assessment leads to two outcomes for patients which include assessment of their medical condition through neurological testing and neurosurgical evaluation for determining which treatments should proceed and when based on their medical condition. Modern functional neurosurgery provides patients with targeted treatment options which include DBS, Thalamotomy, Pallidotomy, Radiofrequency Lesioning and MR-Guided Focused Ultrasound (MRgFUS) for specifically selected patients who require movement disorder treatment. The implementation of advanced imaging systems together with precise targeting abilities and modern technological advancements enables procedures to achieve improved safety levels and enhanced operational efficiency compared to previous times.

Research from around the world shows that patients who get surgery in the early stages of their medical condition experience better results with their motor skills and overall life satisfaction while maintaining higher levels of social and work engagement. The healthcare system needs to draw more attention toward treating disability which happens before patients reach critical impairment because this period provides major advantages which include surgical treatment with higher success rates. Dr. Nayak emphasizes that timely referral is critical, stating that “patients should be evaluated for surgical options when medications start causing side effects or no longer provide consistent control, not years later when options become restricted.”

Dr. Naren Nayak

Phone: +91 9820456326

KIMS Hospitals, Thane, Thane Hiranandani Estate Queens Street, Ghodbunder Rd, opposite BRENTFORD, Patlipada, Thane West, Thane, Maharashtra 400607

Website: https://drnarennayak.com/

If you object to the content of this press release, please notify us at pr.error.rectification@gmail.com. We will respond and rectify the situation within 24 hours.

Related tags : Health

Previous Post

The Conscience Engineer

Next Post

Innovative Egg ‘Rejuvenation’ Techniques Boost IVF Success for Women with Low Ovarian Reserve at Nisha IVF Centre

Related Articles

Health

Raising PCOS Awareness is a key to Empowering Women’s Health

Health

Doctor’s Day 2024: Best Health Experts’ Advice for Taking Care of Your Health

Health

British Wellness Brings A New Era in Affordable Healthcare

Health

Nova 9 Launches Its E-Commerce Solution – Niró9 Advanced Detoxifier & H20 Corrector

Health

Meadbery steps in to promote plant-based supplements for a better health

Recent Posts

  • VAHH Chemicals Limited’s Initial Public Offering Opens on June 4 to June 8, 2026 with Price Fixed at Rs.60 Per Share
  • eYantra Ventures Limited Reports FY26 Annual Results
  • VMS TMT Limited Announces Q4 FY26 and FY26 Results
  • PPMS Group Joins with Prashant Janadri for Activatr – Distribution Platform for Consumer Brands
  • UMC Hospitals, Navi Mumbai Successfully Performs Its First Robotic Surgery

Search

For more Details

editor@bestnewsjournal.com

Recent Posts

  • VAHH Chemicals Limited’s Initial Public Offering Opens on June 4 to June 8, 2026 with Price Fixed at Rs.60 Per Share
  • eYantra Ventures Limited Reports FY26 Annual Results
  • VMS TMT Limited Announces Q4 FY26 and FY26 Results
  • PPMS Group Joins with Prashant Janadri for Activatr – Distribution Platform for Consumer Brands
  • UMC Hospitals, Navi Mumbai Successfully Performs Its First Robotic Surgery
  • Srigee DLM Ltd Announces H2 FY26 and FY26 Results
© 2026 The Prime India | WordPress Theme Ultra News
  • Contact
  • Sample Page
  • Sample Page